A virtual phenotype test provides the same information as a genotype test.
HIV Education
Interactive Clinical Education
Programs (ICEP)
Click here to access the ICEP on virco®TYPE HIV-1 Methodology for Determining Clinical Cut-offs >
Describes the process used by Virco to establish clinical
cut-offs for antiretrovirals used in the treatment of HIV/AIDS.
Dr. Lee Bacheler
Virco Product Monograph
These sets of slides were developed to describe the virco®TYPE HIV-1 Report and to assist HIV clinicians in better understanding the analytical processes used to transform an abundance of data into relevant clinical information. More >
HIV Clinical Updates
This section includes brief clinical bulletins about topics of interest to those involved in the field of HIV resistance. More>
Current Version
The Obama Administration recently made two announcements on national strategies that they hope will help to change the
tide of the HIV/AIDS epidemic in the U.S. by improving care delivery and expanding access to care for people
living with HIV/AIDS.
More >
HIV Resistance Learning System
These modules are presented in an easy to navigate format and beginning with a history of the HIV/ AIDS epidemic and current epidemiology.
Also included are details of the pathophysiology and the science behind the disease, an overview of the drugs used to treat HIV/AIDS and an extensive section on drug resistance and the use of resistance assays to... More >
What's New
These modules are presented in an easy to navigate format and begin with a history of the HIV/AIDS epidemic and current epidemiology.
November 2009
Volume 1, Number 3
Presented by Dr. Rafael E. Campo
A 49-year-old African American male, with a history of IDU, unexpectedly presents to the clinic with viremia and declining CD4 cell count after being lost to follow-up for 2.5 years..
Updated December 1, 2009 — Antiretroviral Guidelines for Adults and Adolescents: Drug Resistance Testing